Text Only Off

Vanderbilt-Ingram Highlights Best of Best from ASCO at its 3rd Annual Oncology Review Symposium

Cancer clinicians from throughout the Southeast gathered over the weekend to learn about the practice-changing implications of research presented at the recent American Society of Clinical Oncology (ASCO) annual meeting.

It was the third annual Oncology Review Symposium hosted by Vanderbilt-Ingram Cancer Center to help clinicians understand the most important and relevant abstracts presented during the recent ASCO meeting.

ASCO’s annual meeting is the largest in the world – the 2006 last month in Atlanta drew nearly 30,000 attendees and included more than 4,400 abstracts presented in 27 different session tracks over four days.

The Oncology Review Symposium on July 8 at the Loews Vanderbilt Plaza:

  • Attracted more than 125 attendees, most of them physicians, from 10 states (Tennessee, Kentucky, Alabama, Mississippi, Georgia, Arkansas, Louisiana, Indiana, South Carolina, and Florida).
  • Featured presentations from 11 faculty representing Vanderbilt-Ingram, Memorial Sloan Kettering Cancer Center, and Emory University-Winship Cancer Institute.
  • Highlighted data from about 70 of the highest-impact abstracts in nine broad cancer categories (non-renal genitourinary cancers; head and neck cancers; renal cancers; melanoma; leukemia and myelodysplastic syndrome; gastrointestinal cancers; breast cancers; lymphoma and multiple myeloma; and lung cancers.

Vanderbilt-Ingram began the symposium in 2004 to address an important unmet educational need of own physicians as well as those throughout the region.

"ASCO’s annual meeting is the largest oncology meeting in the world," said Bruce Roth, MD, professor of Medicine and symposium director. "Many cancer clinicians are unable to attend, and for those who do attend, there is absolutely no way to cover everything because of the sheer volume of information being presented. In fact, the most popular sessions at the ASCO meeting are the ‘Highlights of the Day’ sessions because attendees crave a summary of the best of the best."

Alan Sandler, MD, associate professor of Medicine and Roth’s co-symposium director, agreed.

"We want to distill the overwhelming amount of data into meaningful, concise information that can be put into practice and truly make a difference for cancer patients," he said. "We’ve been very pleased to see both interest and attendance grow with each year we’ve offered this symposium. Providing this type of forum for clinicians throughout the region fits well with our mission as a research and academic-based cancer center and as Tennessee’s only National Cancer Institute Comprehensive Cancer Center."

In addition to Roth and Sandler, speakers at the meeting included Dean Bajorin, MD, from Memorial Sloan Kettering Cancer Center; Ruth O’Regan, MD, from Emory University-Winship Cancer Institute; and from Vanderbilt-Ingram, Christine Chung, MD; Jeff Sosman, MD; Madan Jagasia, MD; Emily Chan, MD, PhD; Jordan Berlin, MD; Ingrid Mayer, MD; and John Greer, MD.